| Application no. and date | 16733812.8 (espacenet) (Federated) (European Patent Register), 20160616 | | Patent/reg. no. and date | DK/EP 3310814, 20230802 | | Publication date | 20180425 | | Priority no. and date | US 201562180459 P, 20150616 | | EP pub. no. and date |
EP 3310814 20180425 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | | Applicant ref. no. | P83150DK01 | | Inventor | HOTZEL, Isidro, 1 DNA Way
South San Francisco, CA 94080-4990, US,
SCHEER, Justin, 1012 Paloma Avenue
Burlingame, CA 94010, US,
SPIESS, Christoph, 1 Dna Way
South San Francisco, CA 94080-4990, US,
JUNTTILA, Teemu, T., 1 DNA Way
South San Francisco, CA 94080-4990, US,
LI, Ji, 1 DNA Way
South San Francisco, CA 94080-4990, US,
DICARA, Danielle, 1 DNA Way
South San Francisco, CA 94080-4990, US,
ELLERMAN, Diego, 1 DNA Way
South San Francisco, CA 94080-4990, US,
CARTER, Paul, 1 DNA Way
South San Francisco, CA 94080-4990, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/28 (2006.01) | | Title | Humaniserede og affinitetsmodnede antistoffer mod FcRH5 og fremgangsmåder til anvendelse | | Int. application no. | US2016037879 | | Int. publication no. | WO2016205520 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
